Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
Clinical trial NCT05687357 · RECRUITING
Trial details
- NCT number
- NCT05687357
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2027-02-28
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.